Two new IPOs -- upsized and over the range -- score $226M and signal a possible comeback for biotech
There are two new biotech IPOs out and trading this morning, and both are offering some preliminary signs that the biotech window is opening up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
